ACTIVE PHARMA SUPPLIES LIMITEDActive

Company number 07940816Private limited companyIncorporated 2012
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.

Key figures

£1,008,574+56.8%
Net assets 2024/25
+64.3%
Average annual growth 2020/21–2024/25
0500 k1 m1.5 m2020/212021/222022/232023/242024/25

Like most small UK companies, ACTIVE PHARMA SUPPLIES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand62,258342,218206,24184,536893,695
Total assets344,474701,044704,274997,4311,571,923
Total liabilities218,216445,148336,084378,672—
Net assets / total equity138,409277,130386,198643,3841,008,574
Average number of employees478100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ACTIVE PHARMA SUPPLIES LIMITED

Company

ACTIVE PHARMA SUPPLIES LIMITED is a private limited company registered with Companies House under company number 07940816. It was incorporated on 8 Feb 2012. Its status is active. The registered office is in Leyland (PR25). Its nature of business (SIC 2007) is wholesale of chemical products (46750).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Net assets were £1,008,574, up 56.8% on the previous year. Cash at bank and in hand was £893,695. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 26 Feb 2027.